| |||||||
Former Names NOD.B6-TgN(KLK4mHEL)6Ccg/Dvs (Changed: 15-DEC-04 ) Type Congenic; Mutant Strain; Transgenic; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Appearance
albino
Related Genotype: A/? Tyrc/TyrcDevelopment
Tg(KLK4mHEL) was backcrossed from C57BL/6-Tg(KLK4mHEL)6Ccg (stock#002598) onto NOD/Lt in the laboratory of Dr. David Serreze. In 2004 this strain reached N13.
Strains carrying Tg(KLK4mHEL)6Ccg allele
002598 C57BL/6-Tg(KLK4mHEL)6Ccg/J View Strains carrying Tg(KLK4mHEL)6Ccg (1 strain)
Strains carrying other alleles of H2-K
000368 B6.C-H2bm1/By 006559 B6.C-H2bm1/ByBir-Gusbmps/BrkJ 000256 B6.C-H2bm1/ByBir-Gusbmps/J 001060 B6.C-H2bm1/ByJ 006558 B6.Cg-H2bm1 Tg(GUSB)4Sly/SndsJ 006877 B6.Cg-Ldlrtm1Her Tg(H2-K-AKR1B1)1Tj/J 002432 B6J x B6.C-H2bm1/ByJ-Cdh23v-J/J 005853 NOD.Cg-Tg(HLA-A2/H2-K)1Scr/ShrmJ View Strains carrying other alleles of H2-K (8 strains)
Strains carrying other alleles of HEL
002599 C57BL/6-Tg(ML5sHEL)5Ccg/J 004252 NOD.B6-Tg(ML5sHEL)5Ccg/Dvs 006610 NOD.B6-Tg(ML5sHEL)5Ccg/DvsJ View Strains carrying other alleles of HEL (3 strains)
Congenic Nomenclature
View Research Applications
Currently there is no phenotype information for this strain.Research Applications
This mouse can be used to support research in many areas including:HEL related
Immunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
| Allele Symbol | Tg(KLK4mHEL)6Ccg | ||
|---|---|---|---|
| Allele Name | transgene insertion 6, Christopher C Goodnow | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | KLK-4; KLK3; mHEL; mHEL-KK; | ||
| Mutation Made By | Christopher Goodnow, Stanford University School of Medicine | ||
| Strain of Origin | C57BL/6 | ||
| Expressed Gene | HEL, HEL, chicken | ||
| Promoter | H2-K, histocompatibility 2, K region, mouse, laboratory | ||
| Molecular Note | A genomic fragment containing the coding exons of the chicken lysozyme gene (also known as hen egg lysozyme, HEL) was linked to the ubiquitously-active mouse H2-Kb promoter and transmembrane sequence (which included the extracellular spacer sequence, transmembrane segment, and cytoplasmic tail). Fluorescence activated cell sorting (FACS) analysis of cells from spleen, lymph node, bone marrow, and thymus from mice carrying the transgene showed membrane expression of chicken lysozyme on these cells. [MGI Ref ID J:78307] | ||
Genotyping Protocols
Tg(KLK4mHEL)6Ccg, Tg(ML5sHEL)5Ccg, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Tg(KLK4mHEL)6Ccg relatedAkkaraju S; Ho WY; Leong D; Canaan K; Davis MM; Goodnow CC. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7(2):255-71. [PubMed: 9285410] [MGI Ref ID J:78309]
Cornall RJ; Cheng AM; Pawson T; Goodnow CC. 2000. Role of Syk in B-cell development and antigen-receptor signaling. Proc Natl Acad Sci U S A 97(4):1713-8. [PubMed: 10677523] [MGI Ref ID J:60647]
Cyster JG; Goodnow CC. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2(1):13-24. [PubMed: 7600299] [MGI Ref ID J:28348]
Hartley SB; Crosbie J; Brink R; Kantor AB; Basten A; Goodnow CC. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353(6346):765-9. [PubMed: 1944535] [MGI Ref ID J:78307]
Hartley SB; Goodnow CC. 1994. Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme-specific antibody. Int Immunol 6(9):1417-25. [PubMed: 7819151] [MGI Ref ID J:132751]
Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW. 2005. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J Immunol 175(2):909-16. [PubMed: 16002689] [MGI Ref ID J:100671]
Kumar KR; Li L; Yan M; Bhaskarabhatla M; Mobley AB; Nguyen C; Mooney JM; Schatzle JD; Wakeland EK; Mohan C. 2006. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312(5780):1665-9. [PubMed: 16778059] [MGI Ref ID J:109640]
Liston A; Gray DH; Lesage S; Fletcher AL; Wilson J; Webster KE; Scott HS; Boyd RL; Peltonen L; Goodnow CC. 2004. Gene dosage--limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med 200(8):1015-26. [PubMed: 15492124] [MGI Ref ID J:93912]
Liu H; Zheng F; Cao Q; Ren B; Zhu L; Striker G; Vlassara H. 2006. Amelioration of oxidant stress by the defensin lysozyme. Am J Physiol Endocrinol Metab 290(5):E824-32. [PubMed: 16317028] [MGI Ref ID J:108413]
Neighbors M; Hartley SB; Xu X; Castro AG; Bouley DM; O'Garra A. 2006. Breakpoints in immunoregulation required for Th1 cells to induce diabetes. Eur J Immunol 36(9):2315-23. [PubMed: 16933361] [MGI Ref ID J:116743]
Pathak S; Ma S; Trinh L; Lu R. 2008. A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol 28(8):2815-24. [PubMed: 18285461] [MGI Ref ID J:133924]
Phan TG; Amesbury M; Gardam S; Crosbie J; Hasbold J; Hodgkin PD; Basten A; Brink R. 2003. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med 197(7):845-60. [PubMed: 12668643] [MGI Ref ID J:132538]
Schram BR; Tze LE; Ramsey LB; Liu J; Najera L; Vegoe AL; Hardy RR; Hippen KL; Farrar MA; Behrens TW. 2008. B cell receptor Basal signaling regulates antigen-induced Ig light chain rearrangements. J Immunol 180(7):4728-41. [PubMed: 18354197] [MGI Ref ID J:133383]
Silveira PA; Dombrowsky J; Johnson E; Chapman HD; Nemazee D; Serreze DV. 2004. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol 172(8):5086-94. [PubMed: 15067092] [MGI Ref ID J:89156]
Silver K; Bouriez-Jones T; Crockford T; Ferry H; Tang HL; Cyster JG; Cornall RJ. 2006. Spontaneous class switching and B cell hyperactivity increase autoimmunity against intracellular self antigen in Lyn-deficient mice. Eur J Immunol 36(11):2920-7. [PubMed: 17039569] [MGI Ref ID J:116999]
Silver K; Ferry H; Crockford T; Cornall RJ. 2006. TLR4, TLR9 and MyD88 are not required for the positive selection of autoreactive B cells into the primary repertoire. Eur J Immunol 36(6):1404-12. [PubMed: 16703567] [MGI Ref ID J:115059]
Zwickey HL; Unternaehrer JJ; Mellman I. 2006. Presentation of self-antigens on MHC class II molecules during dendritic cell maturation. Int Immunol 18(1):199-209. [PubMed: 16361313] [MGI Ref ID J:104201]
Currently there no information available for this strain. This may be due to the supply level of this strain.
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.